RDW 14.5% — the hidden mortality marker on your CBC
Red cell distribution width (RDW) at 14.5% is at the upper boundary of typical reference ranges (11.5–14.5%). RDW measures the heterogeneity of red blood cell size — high RDW means your RBCs vary more in size than expected, which classically indicates iron-deficiency anaemia or B12/folate issues. But the more interesting finding from the past decade of cohort research is that RDW within the 'high-normal' range (12.5–14.5%) is one of the strongest single-marker predictors of all-cause mortality, cardiovascular events, and cancer outcomes — independent of haemoglobin. Why this is true is still debated; chronic inflammation, oxidative stress, and impaired RBC maturation are the leading hypotheses.
Reference ranges
| Standard reference range | 11.5 – 14.5% |
| Optimal (mortality-research) | < 12.5% |
| High-normal (elevated risk) | 12.5 – 14.5% |
| Frankly high | > 14.5% |
What this marker measures
RDW is a coefficient-of-variation measurement — specifically, the standard deviation of red blood cell volume divided by mean cell volume (MCV), expressed as a percentage. A homogeneous population of similarly-sized RBCs gives a low RDW (~12%); a population with mixed sizes (e.g. older microcytic cells alongside fresh normocytic reticulocytes) gives a high RDW. The standard clinical use is to disambiguate types of anaemia. The newer use — informed by studies like the AIRGENE cohort and several large UK Biobank analyses — is as a non-specific marker of physiological stress: chronic inflammation, malnutrition, iron handling dysfunction, and ageing all push RDW up.
Why might it be elevated?
- ·Iron deficiency (often the first abnormality on a CBC; check ferritin)
- ·B12 or folate deficiency
- ·Recent blood loss with reticulocyte burst
- ·Chronic inflammation (IL-6 driven; check hs-CRP)
- ·Chronic kidney disease
- ·Liver disease
- ·Recent transfusion (mixed-cell-age population)
- ·Ageing — RDW slowly rises with age regardless of overt pathology
Why might it be low?
- ·No clinical significance to a low RDW
- ·Healthy young adult with no inflammatory burden
Compounds whose research literature has investigated this area
These are research-grade compounds in our catalogue whose published study literature touches the same biology. Listed for research context — not as recommendations for self-administration.
Nicotinamide adenine dinucleotide — the coenzyme central to cellular electron-transfer, sirtuin signalling, and redox biology.
MOTS-c is a 16-residue peptide encoded in the mitochondrial 12S rRNA region. Described by the Cohen lab in 2015 — studied in metabolic and exercise biology.
FAQ
Why is RDW such a strong mortality predictor?+
The honest answer: nobody fully knows. Leading hypotheses are that RDW captures the cumulative effect of chronic systemic stressors — inflammation, oxidative damage, marrow-output disturbance — that don't show up on any other single CBC marker. A 2007 paper using NHANES III data showed RDW was a stronger all-cause mortality predictor than haemoglobin or MCV.
Does correcting it improve outcomes?+
Where RDW elevation is driven by a correctable cause (iron, B12, folate, chronic inflammation), correction lowers RDW and presumably the associated risk. Whether 'cosmetically' lowering RDW in someone without a deficiency improves outcomes has not been tested — RDW is probably a marker of underlying biology, not the biology itself.
What should I check next?+
Ferritin, B12, folate, hs-CRP, fasting insulin. If iron and inflammation markers are clean, an RDW of 14.5% is not actionable on its own — it goes on the longitudinal panel as a number to watch.
This page describes biomarker research and reference ranges for self-tracking and research-context discussion only. It is not medical advice, not a diagnosis, and not a substitute for a qualified physician. Take any concerns about your health to a clinician.
Have your own panel? Read it next to the standard reference ranges with our free analyse tool.
Analyse my blood work →